Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and protective efficacy of MAM01 in healthy adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MAM01

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Malaria | Phase 1 | Status: COMPLETED